ACB logo

AURORA CANNABIS INC

ACBNASDAQ
Earnings Nov 4US Equity
$3.49β–² $0.72 (+20.59%)
πŸŒ… Pre-market$3.40β–Ό 2.44%Regular close Β· extended-hours price shown
1hβ€”
24hβ–² 20.6%
7dβ–² 20.2%
14dβ–² 28.1%
30dβ–² 30.5%
1yβ–Ό 33.8%
🏦Market Cap
$216M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-6.6%
Declining
πŸ“ŠGross Margin
6.4%
Thin
πŸ’΅FCF Margin
5.0%
Moderate
βš–οΈP/S Ratio
0.8x
Cheap
Otter Score
46
Weak

Trading Snapshot

Day Range
$3.47 – $3.51
52-Week Range
β€”
Volume
$3.71B
Avg Volume
$4.10B
Shares Outstanding
62.0M
Next Earnings
Sep 6, 2026

Fundamentals Snapshot

Annual Revenue
$321M
Last Q Revenue
$68M
P/E Ratio
β€”
P/S Ratio
0.8x
EPS (TTM)
β€”
Dividend Yield
β€”

Why Investors Own ACB

  • βœ“High-growth profile β€” revenue up +1.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 34% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$321Mβ–² +1.9% YoY
Gross Margin (TTM)
33.8%β–Ό βˆ’0.3% YoY
Operating Income (TTM)
$91Mβ–² +1.9% YoY
Free Cash Flow (TTM)
$73Mβ–² +1.9% YoY

About AURORA CANNABIS INC

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
46/100

Analyst Ratings

β“˜
Consensus
Buy
10 analysts
Strong Buy1
Buy5
Hold4
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates